Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Guardant Health Inc - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GH
Nasdaq
2835
https://guardanthealth.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Guardant Health Inc
Guardant Health to Participate in Upcoming Investor Conferences
- May 7th, 2024 8:05 pm
Guardant (GH) Gears Up for Q1 Earnings: Here's What to Expect
- May 7th, 2024 3:29 pm
Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone
- May 7th, 2024 12:00 pm
Curious about Guardant Health (GH) Q1 Performance? Explore Wall Street Estimates for Key Metrics
- May 6th, 2024 1:15 pm
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
- Apr 22nd, 2024 1:00 pm
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
- Apr 22nd, 2024 12:52 pm
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
- Apr 18th, 2024 8:05 pm
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
- Apr 3rd, 2024 12:05 pm
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
- Apr 2nd, 2024 8:02 pm
Better Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks.
- Apr 1st, 2024 12:35 pm
20 Foods To Reduce Cancer Risk
- Mar 30th, 2024 11:43 pm
A blood test for colon cancer performed well in a study, expanding options for screening
- Mar 13th, 2024 9:09 pm
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
- Mar 13th, 2024 9:00 pm
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mar 6th, 2024 9:30 pm
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
- Mar 1st, 2024 10:30 am
21 Countries that Have the Highest Rates of Cancer Deaths
- Feb 28th, 2024 11:46 pm
Guardant Health, Inc. (NASDAQ:GH) Q4 2023 Earnings Call Transcript
- Feb 23rd, 2024 4:48 pm
Guardant Health Insiders Added US$5.05m Of Stock To Their Holdings
- Feb 23rd, 2024 2:24 pm
Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say
- Feb 23rd, 2024 12:00 am
Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates
- Feb 22nd, 2024 11:20 pm
Scroll